These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8969177)

  • 21. Analysis of fragmented oxidized phosphatidylcholines in human plasma using mass spectrometry: Comparison with immune assays.
    Philippova M; Oskolkova OV; Bicker W; Schoenenberger AW; Resink TJ; Erne P; Bochkov VN
    Free Radic Biol Med; 2019 Nov; 144():167-175. PubMed ID: 31141712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
    Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
    Atherosclerosis; 2000 Jan; 148(1):171-7. PubMed ID: 10580183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition.
    Chang MK; Bergmark C; Laurila A; Hörkkö S; Han KH; Friedman P; Dennis EA; Witztum JL
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6353-8. PubMed ID: 10339591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL.
    Nakajima T; Sakagishi Y; Katahira T; Nagata A; Kuwae T; Nakamura H; Inoue I; Takahashi K; Katayama S; Komoda T
    Biochem Biophys Res Commun; 1995 Dec; 217(2):407-11. PubMed ID: 7503715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that human Fc gamma receptor IIA (CD32) subtypes are not receptors for oxidized LDL.
    Morganelli PM; Groveman DS; Pfeiffer JR
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3248-54. PubMed ID: 9409319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.
    Schenkein HA; Berry CR; Purkall D; Burmeister JA; Brooks CN; Tew JG
    Infect Immun; 2001 Nov; 69(11):6612-7. PubMed ID: 11598029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives.
    Rubbo H; Parthasarathy S; Barnes S; Kirk M; Kalyanaraman B; Freeman BA
    Arch Biochem Biophys; 1995 Dec; 324(1):15-25. PubMed ID: 7503550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfer and Enzyme-Mediated Metabolism of Oxidized Phosphatidylcholine and Lysophosphatidylcholine between Low- and High-Density Lipoproteins.
    Sawada N; Obama T; Mizuno M; Fukuhara K; Iwamoto S; Aiuchi T; Makiyama T; Itabe H
    Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33114515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
    Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
    Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody.
    Kim JG; Taylor WR; Parthasarathy S
    Atherosclerosis; 1999 Apr; 143(2):335-40. PubMed ID: 10217362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation.
    Friedman P; Horkko S; Steinberg D; Witztum JL; Dennis EA
    J Biol Chem; 2002 Mar; 277(9):7010-20. PubMed ID: 11744722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
    Radulescu L; Stancu C; Antohe F
    Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appearance of cross linked proteins in human atheroma and rat pre-fibrotic liver detected by a new monoclonal antibody.
    Itabe H; Jimi S; Kamimura S; Suzuki K; Uesugi N; Imanaka T; Shijo H; Takano T
    Biochim Biophys Acta; 1998 Feb; 1406(1):28-39. PubMed ID: 9545523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locally produced anti-phosphorylcholine and anti-oxidized low-density lipoprotein antibodies in gingival crevicular fluid from aggressive periodontitis patients.
    Schenkein HA; Berry CR; Burmeister JA; Brooks CN; Best AM; Tew JG
    J Periodontol; 2004 Jan; 75(1):146-53. PubMed ID: 15025226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
    Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
    Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.
    Podrez EA; Poliakov E; Shen Z; Zhang R; Deng Y; Sun M; Finton PJ; Shan L; Febbraio M; Hajjar DP; Silverstein RL; Hoff HF; Salomon RG; Hazen SL
    J Biol Chem; 2002 Oct; 277(41):38517-23. PubMed ID: 12145296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL.
    Sawada N; Obama T; Koba S; Takaki T; Iwamoto S; Aiuchi T; Kato R; Kikuchi M; Hamazaki Y; Itabe H
    J Lipid Res; 2020 Jun; 61(6):816-829. PubMed ID: 32291330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages.
    Wallner S; Orsó E; Grandl M; Konovalova T; Liebisch G; Schmitz G
    PLoS One; 2018; 13(10):e0205706. PubMed ID: 30308051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.